ADAP 241115 2.50P (ADAP241115P2500) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

ADAP241115P2500

Watchlist

0.00
0.000.00%

15min DelayTrading Nov 12 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

An Overview of Adaptimmune Therapeutics's Earnings
Benzinga11:03 ET
Earnings Preview: ADAP to Report Financial Results Post-market on November 13
Moomoo NewsNov 7 20:00 ET
Express News | Adaptimmune Therapeutics PLC - Receives Nasdaq Notice for Non-Compliance With Minimum Bid Price
ReutersNov 1 17:01 ET
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
newsfileOct 31 17:20 ET
Express News | Adaptimmune Therapeutics: Entered Mutual Release and Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd
ReutersSep 23 16:43 ET
Adaptimmune to Participate in Two Bank Conferences This September
newsfileAug 28 08:00 ET

Comments

101674396

Oct 31 03:35

$Adaptimmune Therapeutics (ADAP.US)$ .. green when is the pre-market , will drop once open market!!!

Trytosaveabit

Sep 23 17:44

Newly filed 8K

$Adaptimmune Therapeutics (ADAP.US)$ Item 1.01Entry into a Material Definitive Agreement.
On September 23, 2024, Adaptimmune Therapeutics plc (the “Company”) entered into a Mutual Release and Resolution Agreement (the “Agreement”) with Genentech Inc and F. Hoffmann-La Roche Ltd, (together “Genentech”). The parties entered into the Agreement following notice of termination of their Collaboration and License Agreement dated September 3, 2021 (the “Collaboration Agreement”) on April 8,...

Tonyco

Sep 8 17:22

$Adaptimmune Therapeutics (ADAP.US)$
so the spike in cash is from financing, fyi

Joy Boy or Bringer

Aug 29 12:36

50% at least please

20% before didn't TP. will wait patiently... or maybe CL...
after the product is approved, profitable, it's your time to shine.
$Adaptimmune Therapeutics (ADAP.US)$

Joy Boy or Bringer

Aug 29 08:43

different respond

hhh not happening for $Adaptimmune Therapeutics (ADAP.US)$
come on

BioCardia Says FDA Has Cleared Company To Market Its Morph DNA Steerable Introducer Product Family, Subject To The General Controls Provisions Of The Federal Food, Drug And Cosmetic Act - Filing